Business Wire

BIBAN

2.3.2023 15:06:42 CET | Business Wire | Press release

Share
Biban 2023: Saudi Arabia’s largest SME conference hosts final round of Entrepreneurship World Cup and other major highlights

Biban, Saudi Arabia’s largest start-up, SME, and entrepreneurship conference, takes place between March 9 and March 13, 2023, at the Riyadh Front Exhibition & Conference Center.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230302005517/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Biban 2023 will feature a diverse range of speakers, high-level talks and sessions throughout its five days (Graphic: AETOSWire)

Biban held its first edition in 2017, and is organized by Monsha’at, the Small and Medium Enterprises General Authority of the Kingdom of Saudi Arabia.

This year, international audiences will benefit from more highlights than ever before, with the forum strongly positioned to foster tangible opportunities.

Biban 2023 will host the Global Finals of the Entrepreneurship World Cup (EWC), one of the biggest and most diverse start-up pitch competitions and support programs of its kind. Since its inception, over 400,000 entrepreneurs from 200 countries have registered. This year, the finalists will compete for up to $1 million in cash prizes.

At Biban 2023, international guests can network and collaborate with government authorities, entrepreneurs, and investors - from the Kingdom and beyond. Additionally, the forum provides access to growing markets, including E-Commerce, FinTech, F&B, and others.

Attendees can also learn about the support - financial and other kinds - that are available to foreigners starting a business in Saudi Arabia.

Making up the engaging themed areas at the forum are nine “Doors”, which include:

  • Start-up Door: Featuring incubators, business accelerators and start-ups
  • Enablement Door: Hosting agencies that enable entrepreneurial business owners
  • Funding Door: Providing start-ups and SMEs with information on where to secure funding and how to overcome financial challenges
  • Growth Door: Educating SME owners on areas that help grow their businesses - marketing, strategy, innovation, and much more

Biban 2023 also welcomes a roster of over 350 speakers from the Kingdom and across the world, which include:

  • HE Lee Young: Minister of SMEs and Start-ups, Republic of Korea
  • Steve Chen: CTO and Co-Founder of YouTube
  • Jeff Hoffman: Chairman of the Board, Global Entrepreneurship Network (GEN)
  • Chris Barton: Founder and Creator of Shazam

Saudi Arabia is emerging as a key player in the global start-up scene. The Global Entrepreneurship Monitor’s (GEM) 2022 National Entrepreneurship Context Index reported that the Kingdom is now the second-best economy in the world to start a business, reflecting a rapidly advancing start-up ecosystem, and a wealth of business opportunities for local and international entrepreneurs.

https://bibanglobal.sa/

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230302005517/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Aqemia and Sanofi Expand Their Research Collaboration17.7.2026 12:30:00 CEST | Press release

A new target nomination and a milestone payment mark the next step of the multi-year partnership first announced in December 2023 Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical company, Sanofi. The expansion is marked by the nomination of a new therapeutic target and an additional payment. The collaboration, first announced in December 2023, makes Aqemia eligible to receive up to a total of $140 million in upfront and milestone payments across programs. It spans the drug discovery journey from the identification of the very first hits to the selection of a development candidate. Aqemia leverages Qemi, its proprietary physics-based generative AI platform, to design novel molecules addressing Sanofi’s targets of choice, working in close collaboration with Sanofi scientific teams. Sanofi leads wet lab research, devel

China's ~$900B Live-Commerce Market Now Approaches US E-Commerce Scale17.7.2026 12:30:00 CEST | Press release

The consumer habits reshaping global retail were built in the East — and most Western shoppers haven't yet adopted them. NIQ report shows that brands still treating live, social, and quick commerce as "emerging" risk being left behind. The center of gravity in global retail has shifted East. The formats now driving the fastest growth in global retail (live shopping, social commerce, and delivery in minutes) were pioneered and scaled in Asia, and most Western consumers have yet to adopt them. According to NIQ (NYSE: NIQ), a leading consumer intelligence company, in its global report The Commerce Revolution: Where East Meets West, the gap between East and West is still vast. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717253489/en/ China´s USD 900bn live shopping boom now approaches the scale of the US E-commerce The scale is already substantial. China's live-commerce market alone was worth roughly $900 billion in 2025,

Ant International’s Alipay+ Connects Argentina's National QR Payment Scheme via PVS,Enabling for Cross-Border Digital Payment Nationwide at Millions of Merchants17.7.2026 12:17:00 CEST | Press release

Alipay+, a global digital payment gateway under Ant International, today announced that it will enable global travellers to make QR code payments at millions of merchants across Argentina through integration with the country's national QR payment scheme Transferencias 3.0, in partnership with PVS, a fintech company specialized in developing customized payment solutions in Latin America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717276406/en/ By connecting to Argentina's national QR payment scheme, Alipay+ now enables global travellers in the country to make convenient QR code payments at merchants nationwide. This service helps to enhance global travellers' travel experiences in Argentina, allowing them to pay seamlessly at restaurants, malls and tourist attractions. Using an Alipay+ partner payment app, they can now scan the national QR code displayed at all merchants to make cross-border payments across Argentina,

KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 09:00:00 CEST | Press release

Where “NO MORE RULES.” intersects with the Kabuku spirit. Inspired by Japanese aesthetics, KATE shares the value of shadow enhancing makeup and self‑expression with the world. Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defi

Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye